Top compounds associated with response to NTN5


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:piperlongumine (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.054 0.1
mRNA Crizotinib gCSI pan-cancer AAC -0.087 0.1
mRNA ruxolitinib GDSC1000 pan-cancer AAC -0.05 0.1
mRNA XAV-939 GDSC1000 pan-cancer AAC -0.052 0.1
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.053 0.1
mRNA YK 4-279 CTRPv2 pan-cancer AAC 0.048 0.1
mRNA HG-5-113-01 GDSC1000 pan-cancer AAC 0.067 0.1
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.048 0.1
mRNA PHA-793887 GDSC1000 pan-cancer AAC 0.042 0.1
mRNA PD-0325901 CCLE pan-cancer AAC -0.062 0.1
Download CSV